92 related articles for article (PubMed ID: 31000515)
1. α
Sugimoto N; Eto K
Blood; 2019 Apr; 133(16):1700-1701. PubMed ID: 31000515
[No Abstract] [Full Text] [Related]
2. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
[TBL] [Abstract][Full Text] [Related]
3. Disrupted filamin A/α
Donada A; Balayn N; Sliwa D; Lordier L; Ceglia V; Baschieri F; Goizet C; Favier R; Tosca L; Tachdjian G; Denis CV; Plo I; Vainchenker W; Debili N; Rosa JP; Bryckaert M; Raslova H
Blood; 2019 Apr; 133(16):1778-1788. PubMed ID: 30602618
[TBL] [Abstract][Full Text] [Related]
4. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets.
Schmitt A; Guichard J; Massé JM; Debili N; Cramer EM
Exp Hematol; 2001 Nov; 29(11):1295-302. PubMed ID: 11698125
[TBL] [Abstract][Full Text] [Related]
5. Anti-platelet drugs: do they affect megakaryocytes?
Cazenave JP; Gachet C
Baillieres Clin Haematol; 1997 Feb; 10(1):163-80. PubMed ID: 9154321
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Significance of Platelet Membrane Glycoprotein GPIIb/IIIa in Diagnosis and Treatment of Immune Thrombocytopenia].
DI ZX; Geng Y; Sun XL; Su AY; Guo K; Li Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1241-1245. PubMed ID: 31418387
[TBL] [Abstract][Full Text] [Related]
7. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed platelet integrin alphaIIbbeta3 in a Fechtner syndrome patient uneventfully undergoing adenotomy.
Sturm A; Speer CP; Grossmann R
Ann Hematol; 2007 May; 86(5):387-8. PubMed ID: 17205288
[No Abstract] [Full Text] [Related]
9. Bernard-Soulier syndrome: quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements.
Tomer A; Scharf RE; McMillan R; Ruggeri ZM; Harker LA
Eur J Haematol; 1994 Apr; 52(4):193-200. PubMed ID: 8005229
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-Function Mutation in Filamin A Potentiates Platelet Integrin α
Berrou E; Adam F; Lebret M; Planche V; Fergelot P; Issertial O; Coupry I; Bordet JC; Nurden P; Bonneau D; Colin E; Goizet C; Rosa JP; Bryckaert M
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1087-1097. PubMed ID: 28428218
[TBL] [Abstract][Full Text] [Related]
11. All in the family: primary megakaryocytes for studies of platelet alphaIIbbeta3 signaling.
Shattil SJ; Leavitt AD
Thromb Haemost; 2001 Jul; 86(1):259-65. PubMed ID: 11487014
[TBL] [Abstract][Full Text] [Related]
12. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets.
Jeske WP; Walenga JM; Szatkowski E; Ero M; Herbert JM; Haas S; Bakhos M
Thromb Res; 1997 Nov; 88(3):271-81. PubMed ID: 9526947
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
Leytin V; Shapiro H; Novikov I; Radnay J
Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb/IIIa antagonists: potential induction and detection of drug-dependent antiplatelet antibodies.
Cines DB
Am Heart J; 1998 May; 135(5 Pt 2 Su):S152-9. PubMed ID: 9588394
[TBL] [Abstract][Full Text] [Related]
16. [New perspectives on the role of αIIbβ3 integrin in defective megakaryopoiesis].
Lebreton L; Tuffigo M; Pillois X; Fiore M
Med Sci (Paris); 2016 Mar; 32(3):290-6. PubMed ID: 27011248
[TBL] [Abstract][Full Text] [Related]
17. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M
Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004
[TBL] [Abstract][Full Text] [Related]
18. Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation.
Lagarrigue F; Gingras AR; Paul DS; Valadez AJ; Cuevas MN; Sun H; Lopez-Ramirez MA; Goult BT; Shattil SJ; Bergmeier W; Ginsberg MH
Blood Adv; 2018 Sep; 2(18):2358-2368. PubMed ID: 30242097
[TBL] [Abstract][Full Text] [Related]
19. The evolution of megakaryocytes to platelets.
Nurden P; Poujol C; Nurden AT
Baillieres Clin Haematol; 1997 Feb; 10(1):1-27. PubMed ID: 9154313
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocytic Smad4 Regulates Platelet Function through Syk and ROCK2 Expression.
Wang Y; Jiang L; Mo X; Lan Y; Yang X; Liu X; Zhang J; Zhu L; Liu J; Wu X
Mol Pharmacol; 2017 Sep; 92(3):285-296. PubMed ID: 28663280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
